skip to content

EPSRC IRC in Targeted Delivery for Hard-to-Treat Cancers

 

The Engineering and Physical Sciences Research Council (EPSRC) Interdisciplinary Research Collaboration (IRC) in Targeted Delivery for Hard-to-Treat Cancers was established in October 2018. It comprises five leading universities (Cambridge, Imperial, UCL, Glasgow & Birmingham) alongside several partner institutions, and aims to develop new technologies capable of enhanced drug delivery for the treatment of four hard-to-treat cancers: mesothelioma, pancreatic cancer, and two types of brain cancer - glioblastoma & ependymoma.